Stock screenerAll disclosures →
EDGAR →
BTAI
Conviction 14HealthcareScan · Thu, Jun 25, 2026BTAI$1.25-4.58%
ResistanceSupportVol 14Insider sell4
Vol MA14 640.99K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price1.25
Change-4.58%
Gap+1.53%
Rel volume0.31×
Avg volume683.76K
Avg $ vol811.72K
SMA 201.18
SMA 501.17
SMA 2001.74
Price vs 50+6.76%
Price vs 200-28.20%
MA stackmixed
50/200 cross—
Supertrendup · 1.07
RSI (14)55
MACD hist0.02
MACD crossbull · 6d
Stoch %K / %D65 / 75
ADX (14)30
+DI / −DI33 / 13
RSI divergenceBullish
MACD divergence—
ATR %+6.67%
ADR %6.87%
52w high6.80
52w low1.02
From 52w high-81.62%
Above 52w low+22.55%
New 52w highNo
SqueezeOff
Bollinger width22.78%
%B0.74
Donchian pos63.49%
Donchian high1.37
Donchian low1.05
AVWAP (52w high)3.54
vs AVWAP high-64.73%
AVWAP (52w low)1.17
vs AVWAP low+6.43%
OBV trendFlat
Chaikin MF (20)-0.30
Today vs 20d0.31×
Avg vol (14d)640.99K
Avg vol (20d)683.76K
Avg $ vol (20d)811.72K
Market cap38.6M
RS 3m (vs SPY)-20.65%
RS 6m (vs SPY)-32.01%
RS line new highNo
Trend template1/8
Technical rank28.6
1 week+5.04%
1 month+2.46%
3 months-12.59%
6 months-28.16%
1 year-27.75%
YTD-26.47%
P/E-0.55
P/B-0.37
P/S60.12
P/FCF-0.67
EPS-5.73
Div yield—
ROE66.23%
ROA-205.43%
Debt/Eq-0.95
Current0.62
EV/EBITDA-2.43
Gross margin—
Net margin—
Rev growth-71.67%
EPS growth-17.28%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value121.71M
Revenue206K
Net income-12.69M
Gross profit—
Free cash flow-57.62M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out30.88M
Employees29
ListedThu, Mar 8, 2018
Free float26.13M
Float %96.5%
Short interest3.53M
Days to cover4.5d
Short volume30.8%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction14 / 100
Pattern quality—
Tech rank28.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.39
Support1.06
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in BTAI
No recent disclosed trades by Congress in BTAI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in BTAI · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Yocca Frank Chief Scientific Officer · Restricted Stock Units · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Rodriguez Javier See Remarks · Common Stock · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Mehta Vimal CEO and President · Common Stock · 2026-06-15 | Exercise | 219 | — | 2026-06-15 | 2026-06-17 |
Yocca Frank Chief Scientific Officer · Common Stock · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Steinhart Richard I Chief Financial Officer · Common Stock · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Steinhart Richard I Chief Financial Officer · Restricted Stock Units · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Mehta Vimal CEO and President · Restricted Stock Units · 2026-06-15 | Exercise | 219 | — | 2026-06-15 | 2026-06-17 |
Rodriguez Javier See Remarks · Restricted Stock Units · 2026-06-15 | Exercise | 35 | — | 2026-06-15 | 2026-06-17 |
Yocca Frank Chief Scientific Officer · Common Stock · 2026-05-20 | Sell | 6.84K | $7K | 2026-05-20 | 2026-05-22 |
Mehta Vimal CEO and President · Common Stock · 2026-05-20 | Sell | 19.42K | $21K | 2026-05-20 | 2026-05-22 |
SEC filings
EDGAR filings in BTAI
No recent SEC filings on file for BTAI.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.